![]() |
![]() |
![]() 3D structures of Coronavirus SARS-CoV-2 proteins and related drugs in HOMCOS server |
![]() |
![]() |
AC | ID | length (amino acids) |
short name | full name |
![]() |
A0A663DJA2_SARS2 | 38 | ||
![]() |
AP3A_SARS2 | 275 | ORF3a; | ORF3a protein; Accessory protein 3a;Protein 3a;Protein U274;Protein X1; |
![]() |
NCAP_SARS2 | 419 | N; NC ;Protein N ; | Nucleoprotein ; Nucleocapsid protein ; |
![]() |
NS6_SARS2 | 61 | ORF6; ns6; | ORF6 protein; Accessory protein 6;Non-structural protein 6;Protein X3; |
![]() |
NS7A_SARS2 | 121 | ORF7a; | ORF7a protein; Accessory protein 7a;Protein U122;Protein X4; |
![]() |
NS7B_SARS2 | 43 | ORF7b; | ORF7b protein; Accessory protein 7b; |
![]() |
NS8_SARS2 | 121 | ORF8; ns8; | ORF8 protein; Non-structural protein 8; |
![]() |
ORF9B_SARS2 | 97 | ORF9b; | ORF9b protein; Accessory protein 9b;ORF-9b;Protein 9b; |
![]() |
R1AB_SARS2 | 7096 | pp1ab; | Replicase polyprotein 1ab; ORF1ab polyprotein; |
![]() |
R1A_SARS2 | 4405 | pp1a; | Replicase polyprotein 1a; ORF1a polyprotein; |
![]() |
SPIKE_SARS2 | 1273 | S glycoprotein ; | Spike glycoprotein ; E2 ;Peplomer protein ; |
![]() |
VEMP_SARS2 | 75 | E;sM protein ; | Envelope small membrane protein ; |
![]() |
VME1_SARS2 | 222 | M; | Membrane protein ; E1 glycoprotein ;Matrix glycoprotein ;Membrane glycoprotein ; |
![]() |
ORF9C_SARS2 | 73 | ORF9c; ORF14; | ORF9c protein ; Uncharacterized protein 14; |
![]() |
AP3A_SARS | 274 | ORF3a protein; Accessory protein 3a;Protein 3a;Protein U274;Protein X1; | |
![]() |
NCAP_SARS | 422 | NC ;Protein N ; | Nucleoprotein ; Nucleocapsid protein ; |
![]() |
NS3B_SARS | 154 | ns3b; | ORF3b protein; Accessory protein 3b;Non-structural protein 3b;Protein X2; |
![]() |
NS6_SARS | 63 | ns6; | ORF6 protein; Accessory protein 6;Non-structural protein 6;Protein X3; |
![]() |
NS7A_SARS | 122 | ORF7a protein; Accessory protein 7a;Protein U122;Protein X4; | |
![]() |
NS7B_SARS | 44 | ns7b; | Protein non-structural 7b; Accessory protein 7b; |
![]() |
NS8A_SARS | 39 | ns8a; | ORF8a protein; Accessory protein 8a;Protein non-structural 8a; |
![]() |
NS8B_SARS | 84 | ns8b; | ORF8b protein; Accessory protein 8b;Non-structural protein 8b; |
![]() |
ORF9B_SARS | 98 | ORF9b protein; Accessory protein 9b;ORF-9b;Protein 9b; | |
![]() |
R1AB_SARS | 7073 | pp1ab; | Replicase polyprotein 1ab; ORF1ab polyprotein; |
![]() |
R1A_SARS | 4382 | pp1a; | Replicase polyprotein 1a; ORF1a polyprotein; |
![]() |
SPIKE_SARS | 1255 | S glycoprotein ; | Spike glycoprotein ; E2 ;Peplomer protein ; |
![]() |
VEMP_SARS | 76 | E protein ;sM protein ; | Envelope small membrane protein ; |
![]() |
VME1_SARS | 221 | M protein ; | Membrane protein ; E1 glycoprotein ;Matrix glycoprotein ;Membrane glycoprotein ; |
![]() |
Y14_SARS | 70 | Uncharacterized protein 14; | |
![]() |
ACE2_HUMAN | 805 | ACEH ;ACE-related carboxypeptidase; | Angiotensin-converting enzyme 2; Angiotensin-converting enzyme homolog ;Angiotensin-converting enzyme-related carboxypeptidase ;Metalloprotease MPROT15 {ECO:0000303|Ref.6}; |
![]() |
BST2_HUMAN | 180 | BST-2; | Bone marrow stromal antigen 2; HM1.24 antigen;Tetherin; |
![]() |
DDX1_HUMAN | 740 | DBP-RB; | ATP-dependent RNA helicase DDX1; DEAD box protein 1;DEAD box protein retinoblastoma; |
![]() |
FURIN_HUMAN | 794 | PACE; | Furin; Dibasic-processing enzyme;Paired basic amino acid residue-cleaving enzyme; |
![]() |
IMA1_HUMAN | 529 | Importin subunit alpha-1 ; Karyopherin subunit alpha-2;RAG cohort protein 1;SRP1-alpha; | |
![]() |
ITAL_HUMAN | 1170 | LFA-1A; | Integrin alpha-L; CD11 antigen-like family member A;Leukocyte adhesion glycoprotein LFA-1 alpha chain;Leukocyte function-associated molecule 1 alpha chain; |
![]() |
MPP5_HUMAN | 675 | MAGUK p55 subfamily member 5; | |
![]() |
PHB2_HUMAN | 299 | Prohibitin-2; B-cell receptor-associated protein BAP37;D-prohibitin;Repressor of estrogen receptor activity; | |
![]() |
PHB_HUMAN | 272 | Prohibitin ; | |
![]() |
SGTA_HUMAN | 313 | UBP; | Small glutamine-rich tetratricopeptide repeat-containing protein alpha; Alpha-SGT;Vpu-binding protein; |
![]() |
SMAD3_HUMAN | 425 | MAD homolog 3;Mad3;Mothers against DPP homolog 3;hMAD-3; SMAD 3;Smad3;hSMAD3; | Mothers against decapentaplegic homolog 3; JV15-2;SMAD family member 3; |
![]() |
TMPS2_HUMAN | 492 | Transmembrane protease serine 2 ; Serine protease 10 ; | |
![]() |
AMPN_HUMAN | 967 | AP-N;hAPN; AP-M; | Aminopeptidase N ; Alanyl aminopeptidase;Aminopeptidase M;Microsomal aminopeptidase;Myeloid plasma membrane glycoprotein CD13;gp150; |
![]() |
IL6RA_HUMAN | 468 | IL-6 receptor subunit alpha;IL-6R subunit alpha;IL-6R-alpha;IL-6RA; gp80; | Interleukin-6 receptor subunit alpha ; IL-6R 1;Membrane glycoprotein 80; |
![]() |
IL6RB_HUMAN | 918 | IL-6 receptor subunit beta;IL-6R subunit beta;IL-6R-beta;IL-6RB; gp130 ; | Interleukin-6 receptor subunit beta ; CDw130;Interleukin-6 signal transducer;Membrane glycoprotein 130;Oncostatin-M receptor subunit alpha; |
![]() |
IL6_HUMAN | 212 | IL-6; BSF-2;CDF;IFN-beta-2; | Interleukin-6 ; B-cell stimulatory factor 2;CTL differentiation factor;Hybridoma growth factor;Interferon beta-2; |
protein_id | length (amino acids) |
product | gene | note |
![]() |
7096 | 2'-O-ribose methyltransferase | orf1ab | pp1ab; translated by -1 ribosomal frameshift |
![]() |
180 | leader protein | nsp1; produced by both pp1a and pp1ab | |
![]() |
638 | nsp2 | produced by both pp1a and pp1ab | |
![]() |
1945 | nsp3 | former nsp1; conserved domains are: N-terminal | |
![]() |
500 | nsp4 | nsp4B_TM; contains transmembrane domain 2 (TM2); | |
![]() |
306 | 3C-like proteinase | nsp5A_3CLpro and nsp5B_3CLpro; main proteinase | |
![]() |
290 | nsp6 | nsp6_TM; putative transmembrane domain; produced by | |
![]() |
83 | nsp7 | produced by both pp1a and pp1ab | |
![]() |
198 | nsp8 | produced by both pp1a and pp1ab | |
![]() |
113 | nsp9 | ssRNA-binding protein; produced by both pp1a and | |
![]() |
139 | nsp10 | nsp10_CysHis; formerly known as growth-factor-like | |
![]() |
932 | RNA-dependent RNA polymerase | nsp12; NiRAN and RdRp; produced by pp1ab only | |
![]() |
601 | helicase | nsp13_ZBD, nsp13_TB, and nsp_HEL1core; zinc-binding | |
![]() |
527 | 3'-to-5' exonuclease | nsp14A2_ExoN and nsp14B_NMT; produced by pp1ab | |
![]() |
346 | endoRNAse | nsp15-A1 and nsp15B-NendoU; produced by pp1ab only | |
![]() |
298 | 2'-O-ribose methyltransferase | nsp16_OMT; 2'-o-MT; produced by pp1ab only | |
![]() |
4405 | nsp11 | orf1ab | pp1a |
![]() |
13 | nsp11 | produced by pp1a only | |
![]() |
1273 | surface glycoprotein | S | structural protein; spike protein |
![]() |
275 | ORF3a protein | ORF3a | |
![]() |
75 | envelope protein | E | ORF4; structural protein; E protein |
![]() |
222 | membrane glycoprotein | M | ORF5; structural protein |
![]() |
61 | ORF6 protein | ORF6 | |
![]() |
121 | ORF7a protein | ORF7a | |
![]() |
43 | ORF7b | ORF7b | |
![]() |
121 | ORF8 protein | ORF8 | |
![]() |
419 | nucleocapsid phosphoprotein | N | ORF9; structural protein |
![]() |
38 | ORF10 protein | ORF10 |
KEGG_ID | structure | NAME | OTHER NAME | EFFICACY |
![]() |
D01703 Ciclesonide (JAN/USAN/INN); Alvesco (TN); Omnaris (TN); Zetonna (TN) | Alvesco (TN); Omnaris (TN); Zetonna (TN) | Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist | |
![]() |
D01425 Lopinavir (JAN/USP/INN) | Antiviral, HIV protease inhibitor | ||
![]() |
D00427 Ritonavir (JAN/USP/INN); Norvir (TN) | Norvir (TN) | Antiviral, HIV protease inhibitor | |
![]() |
D09537 Favipiravir (JAN/USAN/INN); Avigan (TN) | Avigan (TN) | Antiviral, RNA replicase inhibitor | |
![]() |
D09537_1 Favipiravir-MTP; Active form of Favipiravir; | Active form of Favipiravir; | Antiviral, RNA replicase inhibitor | |
![]() |
D09537_2 Favipiravir-DTP; Active form of Favipiravir; | Active form of Favipiravir; | Antiviral, RNA replicase inhibitor | |
![]() |
D09537_3 Favipiravir-RTP; Active form of Favipiravir; | Active form of Favipiravir; | Antiviral, RNA replicase inhibitor | |
![]() |
D11472 Remdesivir (JAN/USAN); Veklury (TN) | Veklury (TN) | Antiviral, RNA polymerase inhibitor | |
![]() |
D11472_1 Remdesivir-monophosphate (USAN | Antiviral | ||
![]() |
D11472_2 Remdesivir-diphosphate (USAN | Antiviral | ||
![]() |
D11472_3 Remdesivir-triphosphate (USAN | Antiviral | ||
![]() |
D02366 Chloroquine (USP/INN) | Antimalarial, Amebicide | ||
![]() |
D08050 Hydroxychloroquine (INN); Polirreumin (TN) | Polirreumin (TN) | Antimalarial | |
![]() |
D01670 Nafamostat mesylate (USAN); Nafamostat mesilate (JP17); Ronastat (TN) | Nafamostat mesilate (JP17); Ronastat (TN) | Anticoagulant, Antifibrinolytic, Serine protease inhibitor | |
![]() |
D00429 Saquinavir (JAN/USP/INN); Fortovase (TN) | Fortovase (TN) | Antiviral, HIV protease inhibitor | |
![]() |
D01035 Cepharanthine (JAN); Cepharanthine (TN) | Cepharanthine (TN) | Antiallergic, Blood circulation promotor | |
![]() |
D00804 Ivermectin (JAN/USP/INN); Sklice (TN); Soolantra (TN); Stromectol (TN) | Sklice (TN); Soolantra (TN); Stromectol (TN) | Antiparasitic | |
![]() |
D00292 Dexamethasone (JP17/USP/INN); Decadron (TN); Maxidex (TN) | Decadron (TN); Maxidex (TN) | Anti-inflammatory, Antipruritic, Glucocorticoid receptor agonist | |
![]() |
D07486 Azithromycin (INN); Azasite (TN); Azithromycin (TN) | Azasite (TN); Azithromycin (TN) | Antibacterial, Protein biosynthesis inhibitor |
HOMCOS is developed and maintained by Protein Data Bank Japan, IPR, Osaka University. It is now supported by the project "Platform for Drug Discovery, Informatics, and Structural Life Science" by MEXT, Japan.
References